Drug Interactions Workshop

The CAPhO Drug Interactions Workshop took place virtually on Saturday, May 30, 2020 at 10am PDT, 11am MDT, 12pm CDT, 1pm EDT, 2pm ADT. 

We are offering CAPhO members the opportunity to participate in this virtual workshop at no charge. In return, CAPhO is asking for your active participation during the entire workshop, as well as your feedback afterwards to help us improve delivery of future virtual workshops. The workshop is scheduled to run for approximately 3.5 hours and is accredited for 4.2 CEUs by the Canadian Council on Continuing Education in Pharmacy (CCCEP). 

Registration
Session Description
Case Authors, Reviewers, Facilitators, Webinar Creators
Learning Objectives
Accreditation

Details

In small groups, you will work through drug interaction cases with the support of expert facilitators. The cases will be typical of clinically relevant drug interactions you will encounter in oncology pharmacy practice. You and your group will make a series of decisions including interpretation of the drug interaction resource information, prioritization of drug interactions, development of a pharmaceutical care plan including a recommendation, clinical rationale, communication of your plan, and creation of a patient follow up and/or monitoring plan.

Session Descriptions

Case 1: Ribociclib and QTc Prolongation

Author: Nicole MacDonald, Dr. H. Bliss Murphy Cancer Centre, Eastern Health, St. Johns, NL

Case 2: Antiretroviral Drug Interactions in Oncology

(This case was used in the 2019 Drug Interactions Workshop)

Author: Marie J. Bravo-Ko, Celgene Inc., ON

Case 3: Immune Checkpoint Inhibitor (ICI) in an Oncology Patient with a pre-existing Autoimmune Disease (AID)

Author: Tara Leslie, BSP, BCOP, Clinical Assistant Professor, Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Calgary, Alberta 

Case Authors

Iryna Knyazevych

Nicole MacDonald, BScPharm, ACPR, Clinical Pharmacist – Medical Oncology, Dr. H Bliss Murphy Cancer Centre – Eastern Health, NL

Nicole MacDonald is a clinical medical oncology pharmacist at the Dr. H. Bliss Murphy Cancer Centre in St. John’s, Newfoundland. She graduated from Memorial University in 2015 and went on to complete a hospital residency in Moncton, New Brunswick in 2016. She is currently completing her Doctor of Pharmacy through the University of Toronto. She has worked in oncology since 2016 with experience in a variety of areas and has a focus on breast cancer. She is currently a member of the CAPhO Drug Interactions Module Task Force.

Marie Jam Bravo

Marie J. Bravo-Ko, PharmD, RPh, ACPR, Regional Medical Liaison – Hematology/Oncology, Celgene Inc., Mississauga, Ontario  

Marie (Jam) Bravo-Ko is a Medical Science Liaison in Hematology/Oncology at AstraZeneca. She received her PharmD from the University of Toronto in 2015 and subsequently completed the Hospital Pharmacy Residency Program at the University Health Network in 2016. She is a former malignant hematology clinical pharmacist at Princess Margaret Cancer Centre. She was also a consultant clinical pharmacist at Casey House, Canada's first and only stand-alone hospital for people with HIV/AIDS. 

Tara Leslie, BSP, BCOP, APA, Clinical Pharmacist and Clinical Assistant Professor, Tom Baker Cancer Centre, and Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Alberta

Tara attained her Bachelor of Science in Pharmacy (BSP) degree from the University of Saskatchewan in 1997, obtained her Board Certification in Oncology Pharmacy (BCOP) in 2010, and acquired her Additional Prescribing Authority (APA) in 2013. She recently completed a Masters of Education in Health Sciences Education (MEd HSE) program with the University of Alberta and will graduate this spring.  She is a Clinical Assistant Professor with the Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta where she teaches oncology related curriculum in a variety of courses and is a part of the experiential education team. Tara maintains a clinical practice within an ambulatory hematology/oncology clinic at the Tom Baker Cancer Centre.  She is an active member of CAPhO.  

 

Case Reviewers

Melanie Danilak

Melanie Danilak, BSc. Pharm, ACPR, MEd, Clinical Practice Leader, Alberta Health Services, Alberta

Melanie is a Clinical Practice Leader and Residency Coordinator with Alberta Health Services and maintains a clinical practice in an osteoporosis as well as a rheumatology-immuno-oncology clinic.  She is a clinical adjunct professor with the Faculty of Pharmacy & Pharmaceutical Sciences at the University of Alberta.  In addition to being an active CAPhO member, Melanie is a board member on the Canadian Pharmacy Residency Board.

Danica Wasney

Danica Wasney, B.Sc. Pharm, ACPR, BCOP, Clinical Pharmacist, CancerCare Manitoba, Manitoba

Danica Wasney is a clinical pharmacist at CancerCare Manitoba where she works within Provincial Oncology Drug Program on the provincial implementation of new systemic therapies, including co-chairing the Formulary Management Team.  She is a past member of the Expert Review Committee for the pan-Canadian Oncology Drug Review (pCODR) at the Canadian Agency for Drugs and Technologies in Health (CADTH).

She graduated from the Faculty of Pharmacy at University of Manitoba and completed an Accredited Hospital Pharmacy Residency at The Ottawa Hospital.  She is a Board Certified Oncology Pharmacist, a member of the CAPhO Research Committee, and a past member of the CAPhO Education Committee.

 

Workshop Facilitators

Jennifer Jupp

Kyla Bailey, BSP, Hematology/BMT Clinical Pharmacist – Tom Baker Cancer Centre, Calgary

Kyla graduated from University of Saskatchewan in 2003 and currently works for Alberta Health Services at the Tom Baker Cancer Centre as a clinical hematology/BMT pharmacist. She has practiced in many diverse settings, including community, geriatrics, hospital outpatient, and oncology. Since joining the Tom Baker Cancer Centre in 2014, she first developed her oncology clinical skills in the Oral Chemotherapy Management program, before moving into the Hematology and Bone Marrow Transplant clinics.  She obtained her Advanced Prescribing rights in 2014, which allows pharmacist-led supportive care management.  Kyla continues to be involved as a preceptor for the Alberta Health Services Residents and the University of Alberta PharmD students during their hematology rotations.

Tara Leslie

Tara Leslie, BSP, BCOP, APA, Clinical Pharmacist and Clinical Assistant Professor, Tom Baker Cancer Centre, and Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Alberta

Tara attained her Bachelor of Science in Pharmacy (BSP) degree from the University of Saskatchewan in 1997, obtained her Board Certification in Oncology Pharmacy (BCOP) in 2010, and acquired her Additional Prescribing Authority (APA) in 2013. She recently completed a Masters of Education in Health Sciences Education (MEd HSE) program with the University of Alberta and will graduate this spring.  She is a Clinical Assistant Professor with the Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta where she teaches oncology related curriculum in a variety of courses and is a part of the experiential education team. Tara maintains a clinical practice within an ambulatory hematology/oncology clinic at the Tom Baker Cancer Centre.  She is an active member of CAPhO.  

Glenn Myers

Glenn Myers, BScPharm, ACPR, Clinical Oncology Pharmacist, Ambulatory Oncology, Horizon Health Network, New Brunswick

Glenn is a clinical pharmacist in outpatient oncology and emergency medicine at The Moncton Hospital in Moncton, New Brunswick. Glenn completed a BSc (Pharmacy) at Dalhousie University in 2011 and subsequently went on to complete his hospital residency at the Saint John Regional Hospital in Saint John, NB. Glenn has been in oncology for 6 years and focuses on clinical assessment and management of chemotherapy and immune related adverse effects. Glenn enjoys teaching and mentoring various levels of pharmacy learners, as well as providing education to healthcare professionals regarding oncology therapeutics.

 

Webinar Creators

Gabriel Gazze

Stephanie Lovering, BSc(Hon), BScPhm, PharmD, ACPR, Clinical Pharmacist – Medical Oncology, The Ottawa Hospital, Ontario

Stephanie Lovering received her Bachelor of Science in Pharmacy and Post-Baccalaureate Doctor of Pharmacy degrees from the University of Toronto. Prior to pharmacy, Stephanie completed a Bachelor of Science degree with a subject of specialization in Life Sciences at Queen’s University at Kingston, Ontario. She completed a Pharmacy Residency at Mount Sinai Hospital in Toronto, Ontario. She has been practicing in oncology for three years and is currently a clinical pharmacist in inpatient medical oncology at The Ottawa Hospital.

Louisa Pang

Jason Wentzell, BScPharm, ACPR, BCOP, MHM, Founder & Oncology Pharmacist Extend Pharmacy

Jason completed his pharmacy degree at Dalhouise University and his Pharmacy Residency at The Ottawa Hospital.  He has practiced as an inpatient Medical Oncology pharmacist for nearly 10 years, from 2010 to 2019 and is a Board-Certified Oncology Pharmacist.  He has earned a Master’s in Health Management in 2019.  Jason is the Founder of and Oncology Pharmacist at Extend Pharmacy, Ottawa’s first cancer-focused ambulatory oncology pharmacy. His areas of research interest include integration of pharmacy learners into practice, simulation education, oral anticancer therapy education and key performance indicators for pharmacists.  He is currently involved in several CAPhO initiatives and is a Regional Clinical Coordinator for the University of Waterloo PharmD program in Ottawa.     

 

Workshop Learning Objectives

  • Assessing patient information and evaluating drug interaction resource materials to identify and prioritize drug interactions commonly seen in oncology practice.
  • Integrating critical thinking and “shared decision making” into drug interaction assessment to develop appropriate recommendations and create suitable monitoring plans.
  • Communicating drug interaction(s) with patients and/or care team providers.

Accreditation

The Canadian Council on Continuing Education in Pharmacy (CCCEP) is a national organization established to accredit continuing pharmacy education programs intended to be delivered to pharmacy professionals from more than one province or nationally. CCCEP accreditation is recognized by the pharmacy regulatory authorities in all provinces and territories of Canada.

The Drug Interactions Live Workshop 2020 is accredited for 4.2 continuing education credits (CEUs).